Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

This study has been completed.

Study NCT00025038 Information provided by National Cancer Institute (NCI)

First Received: October 11, 2001 Last Updated: December 17, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Publications:

Castleberry RP, Loh ML, Jayaprakash N, et al.: Phase II window study of the farnesyltransferase inhibitor R115777 (Zarnestra®) in untreated juvenile myelomonocytic leukemia (JMML): a Children's Oncology Group Study. [Abstract] Blood 106 (11): A-2587, 2005.